{
    "title": "AstraZeneca boss David Brennan steps down as profits tumble",
    "url": "https://www.dailymail.co.uk/money/markets/article-2135438/AstraZeneca-boss-David-Brennan-steps-profits-tumble.html",
    "date": "2012-04-26",
    "keywords": [
        "executive",
        "company",
        "brennan",
        "cent",
        "astrazeneca",
        "profit",
        "david",
        "end",
        "series",
        "drug",
        "development",
        "companys",
        "patent",
        "year",
        "boss",
        "money",
        "reporter",
        "gmt",
        "april",
        "view",
        "today",
        "june",
        "tenure",
        "pressure",
        "blow",
        "cover",
        "topdrawer",
        "treatment",
        "era",
        "cancer",
        "olaparib",
        "blockbuster",
        "share",
        "price",
        "shell",
        "back",
        "oil",
        "petrol",
        "news",
        "departure",
        "dive",
        "loss",
        "exclusivity",
        "percentage",
        "revenue",
        "drop",
        "hit",
        "seroquel",
        "announcement",
        "simon",
        "director",
        "officer",
        "successor",
        "retirement",
        "time",
        "leader",
        "impact",
        "world",
        "value"
    ],
    "category": [
        "money",
        "markets"
    ]
}